Education
About Us
Working with TipRanks
Follow Us
Nectar Lifesciences Ltd. (IN:NECLIFE)
:NECLIFE
RESEARCH TOOLSreports
NECLIFE Analyst Ratings
Hold
0 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
NECLIFE Stock 12 Month Forecast
Average Price Target
₹14.50
▼(-8.17% Downside)
| Highest Price Target₹14.50 | Average Price Target₹14.50 | Lowest Price Target₹14.50 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TR | OpenAI - 4o
₹14.5
Hold
-8.17%
Downside
Initiated
08/06/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TR | OpenAI - 4o
₹14.5
Hold
-8.17%
Downside
Initiated
08/06/25
NECLIFE Analyst Recommendation Trends
Rating
Aug 25
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
total
1
Each month's total comprises the sum of three months' worth of ratings.
NECLIFE Financial Forecast
NECLIFE Stock Forecast FAQ
What is IN:NECLIFE’s average 12-month price target, according to analysts?
Based on analyst ratings, Nectar Lifesciences Ltd.’s 12-month average price target is 14.50.
What is IN:NECLIFE’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:NECLIFE, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Nectar Lifesciences Ltd. a Buy, Sell or Hold?
Nectar Lifesciences Ltd. has a consensus rating of Hold, which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
What is Nectar Lifesciences Ltd.’s share price target?
The average share price target for Nectar Lifesciences Ltd. is 14.50. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is ₹14.50 ,and the lowest forecast is ₹14.50. The average share price target represents -8.17% Decrease from the current price of ₹15.79.
The highest analyst share price target is ₹14.50 ,and the lowest forecast is ₹14.50. The average share price target represents -8.17% Decrease from the current price of ₹15.79.
What do analysts say about Nectar Lifesciences Ltd.?
Nectar Lifesciences Ltd.’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of Nectar Lifesciences Ltd.?
To buy shares of IN:NECLIFE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.